JP2013513607A5 - - Google Patents

Download PDF

Info

Publication number
JP2013513607A5
JP2013513607A5 JP2012543187A JP2012543187A JP2013513607A5 JP 2013513607 A5 JP2013513607 A5 JP 2013513607A5 JP 2012543187 A JP2012543187 A JP 2012543187A JP 2012543187 A JP2012543187 A JP 2012543187A JP 2013513607 A5 JP2013513607 A5 JP 2013513607A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutically acceptable
salt
group
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012543187A
Other languages
English (en)
Japanese (ja)
Other versions
JP5631411B2 (ja
JP2013513607A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/059158 external-priority patent/WO2011071840A1/en
Publication of JP2013513607A publication Critical patent/JP2013513607A/ja
Publication of JP2013513607A5 publication Critical patent/JP2013513607A5/ja
Application granted granted Critical
Publication of JP5631411B2 publication Critical patent/JP5631411B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012543187A 2009-12-10 2010-12-07 ジアシルグリセロールアシルトランスフェラーゼの阻害剤 Expired - Fee Related JP5631411B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28531709P 2009-12-10 2009-12-10
US61/285,317 2009-12-10
PCT/US2010/059158 WO2011071840A1 (en) 2009-12-10 2010-12-07 Inhibitors of diacylglycerol acyltransferase

Publications (3)

Publication Number Publication Date
JP2013513607A JP2013513607A (ja) 2013-04-22
JP2013513607A5 true JP2013513607A5 (enExample) 2013-11-21
JP5631411B2 JP5631411B2 (ja) 2014-11-26

Family

ID=43569741

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012543187A Expired - Fee Related JP5631411B2 (ja) 2009-12-10 2010-12-07 ジアシルグリセロールアシルトランスフェラーゼの阻害剤

Country Status (14)

Country Link
US (1) US8299061B2 (enExample)
EP (1) EP2509981B1 (enExample)
JP (1) JP5631411B2 (enExample)
KR (1) KR101395428B1 (enExample)
CN (1) CN102666543B (enExample)
AR (1) AR079170A1 (enExample)
AU (1) AU2010328410B2 (enExample)
BR (1) BR112012013918A2 (enExample)
CA (1) CA2783684C (enExample)
EA (1) EA020128B1 (enExample)
ES (1) ES2509922T3 (enExample)
MX (1) MX2012006646A (enExample)
TW (1) TWI392680B (enExample)
WO (1) WO2011071840A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3056486B1 (en) 2010-07-16 2018-07-11 AbbVie Ireland Unlimited Company Process for preparing intermediates for antiviral compounds
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
EP3461556A1 (en) 2010-07-16 2019-04-03 AbbVie Ireland Unlimited Company Phosphine ligands for catalytic reactions
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
WO2015120610A1 (en) * 2014-02-14 2015-08-20 Eli Lilly And Company Gpr142 agonist compound
CN105153195B (zh) * 2015-09-01 2017-09-26 汤文建 一种三环吡唑[1,5‑d][1,4]苯并氧氮杂卓酮衍生物及其制备方法与用途
AU2020285269B2 (en) * 2019-05-31 2022-11-17 Medshine Discovery Inc. Bicyclic compound as RIP-1 kinase inhibitor and application thereof
AR122703A1 (es) * 2020-07-01 2022-09-28 Rigel Pharmaceuticals Inc Inhibidores de rip1k

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847248A (en) 1986-12-23 1989-07-11 Merck & Co., Inc. 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists
US4735941A (en) 1986-12-23 1988-04-05 Merck & Co., Inc. 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
EP0272866A1 (en) 1986-12-23 1988-06-29 Merck & Co. Inc. 1,4-Benzodiazepines with 5-membered heterocyclic rings
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them
CA2071092A1 (en) 1991-06-14 1992-12-15 Roger M. Freidinger 1,4-benzodiazepines with 5-membered heterocyclic rings
US5439906A (en) 1993-11-22 1995-08-08 Merck & Co., Inc. Antiarrhythmic benzodiazepines
JP2840454B2 (ja) 1993-11-22 1998-12-24 メルク エンド カンパニー インコーポレーテッド ベンゾジアゼピン類
DE69428546T2 (de) 1993-11-22 2002-04-11 Merck & Co., Inc. 3-acylaminobenzazepine
US5834464A (en) 1994-11-18 1998-11-10 Merck & Co., Inc. Imidazolinobenzodiazepines
HRP970705A2 (en) 1996-12-23 1998-10-31 Warren J. Porter CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING "beta" -AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
GB0012671D0 (en) 2000-05-24 2000-07-19 Merck Sharp & Dohme Therapeutic agents
AU2005272627A1 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
CN101171231A (zh) * 2005-05-10 2008-04-30 霍夫曼-拉罗奇有限公司 二酰基甘油酰基转移酶抑制剂
JP2009502929A (ja) 2005-07-29 2009-01-29 メルク エンド カムパニー インコーポレーテッド ヘテロ環式ベンゾジアゼピンcgrp受容体アンタゴニスト
US7569590B2 (en) 2006-09-19 2009-08-04 Bristol-Myers Squibb Company Use of thianecarboxamides as dgat inhibitors
US8324241B2 (en) 2008-04-11 2012-12-04 Bristol-Myers Squibb Company Triazolo compounds useful as DGAT1 inhibitors
WO2009126861A2 (en) 2008-04-11 2009-10-15 Bristol-Myers Squibb Company Triazolopyridine compounds useful as dgat1 inhibitors
JP2010116364A (ja) * 2008-11-14 2010-05-27 Banyu Pharmaceut Co Ltd アゼピノン誘導体
US20110319396A1 (en) 2009-01-23 2011-12-29 Msd K.K. Benzodiazepin-2-on derivatives
CA2752739A1 (en) 2009-02-17 2010-08-26 Msd K.K. 1,4-benzodiazepin-2-on derivatives

Similar Documents

Publication Publication Date Title
JP2013513607A5 (enExample)
JP2013507423A5 (enExample)
JP2012506896A5 (enExample)
JP2013032389A5 (enExample)
JP2010536766A5 (enExample)
JP2014500861A5 (enExample)
JP2013508279A5 (enExample)
JP2011518833A5 (enExample)
JP2011105738A5 (enExample)
JP2012502037A5 (enExample)
JP2013518107A5 (enExample)
JP2012092103A5 (enExample)
JP2013509429A5 (enExample)
JP2010077141A5 (enExample)
JP2011527299A5 (enExample)
JP2009535462A5 (enExample)
JP2015505296A5 (enExample)
JP2013542247A5 (enExample)
JP2015024998A5 (enExample)
JP2016006118A5 (enExample)
JP2013545785A5 (enExample)
JP2010501534A5 (enExample)
JP2012532883A5 (enExample)
JP2015516427A5 (enExample)
JP2014507477A5 (enExample)